Dinaciclib is currently undergoing phase II clinical trial in the treatment of non-small-cell lung cancer.

By VD/VDR- vd-vdr June 21, 2017

prudect name : Dinaciclib is currently undergoing phase II clinical trial in the treatment of non-small-cell lung cancer.
SCH727965

Synonyms: CAS NO: 779353-01-4Molecular Formula: C₂₁H₂₈N₆O₂Molecular Weight: 396.49Purity: 98% minSolubility: In DMSOStorage: -20°C

web site: www.medchemexpress.com

By VD/VDR- vd-vdr

Conformational Switching Nanoparticles for Precision Cancer Therapy via Tumor Microenvironment-Responsive Disassembly

Robustness and Stability of Molecularly Imprinted Microplates for Long-Term Biopharmaceutical Monitoring

MOF-Derived Hierarchical Fe-Doped Ni@NC Microspheres with Enhanced OER Activity and Stability in Alkaline Media

High-Efficiency Perovskite Solar Cells Based on Dual-Layered Hole Transport Materials with Enhanced Charge Extraction and Stability